These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12210884)

  • 1. Tourettism and dystonia after subcortical stroke.
    Kwak CH; Jankovic J
    Mov Disord; 2002 Jul; 17(4):821-5. PubMed ID: 12210884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary tics or tourettism associated with a brain tumor.
    Luat AF; Behen ME; Juhász C; Sood S; Chugani HT
    Pediatr Neurol; 2009 Dec; 41(6):457-60. PubMed ID: 19931171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.
    Gilbert DL; Bansal AS; Sethuraman G; Sallee FR; Zhang J; Lipps T; Wassermann EM
    Mov Disord; 2004 Apr; 19(4):416-25. PubMed ID: 15077239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome.
    Peterson BS; Thomas P; Kane MJ; Scahill L; Zhang H; Bronen R; King RA; Leckman JF; Staib L
    Arch Gen Psychiatry; 2003 Apr; 60(4):415-24. PubMed ID: 12695320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant Tourette syndrome.
    Cheung MY; Shahed J; Jankovic J
    Mov Disord; 2007 Sep; 22(12):1743-50. PubMed ID: 17566119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome.
    Ghanizadeh A; Mosallaei S
    Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome.
    Gilbert DL; Sallee FR; Zhang J; Lipps TD; Wassermann EM
    Biol Psychiatry; 2005 Jun; 57(12):1597-600. PubMed ID: 15953499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
    Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
    J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
    Erenberg G
    Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of quality of life in children with Gilles de la Tourette syndrome.
    Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG
    Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystonic tics in patients with Tourette's syndrome.
    Jankovic J; Stone L
    Mov Disord; 1991; 6(3):248-52. PubMed ID: 1922130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased event-related theta activity as a psychophysiological marker of comorbidity in children with tics and attention-deficit/hyperactivity disorders.
    Yordanova J; Heinrich H; Kolev V; Rothenberger A
    Neuroimage; 2006 Aug; 32(2):940-55. PubMed ID: 16730196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of Tourette syndrome].
    Debes NM; Hjalgrim H; Skov L
    Ugeskr Laeger; 2008 Aug; 170(35):2701-3. PubMed ID: 18761861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineuronal antibodies: tics and obsessive-compulsive symptoms.
    Kiessling LS; Marcotte AC; Culpepper L
    J Dev Behav Pediatr; 1994 Dec; 15(6):421-5. PubMed ID: 7884013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome.
    Mol Debes NM; Hjalgrim H; Skov L
    J Child Neurol; 2008 Sep; 23(9):1017-27. PubMed ID: 18827268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations.
    Mathews CA; Jang KL; Herrera LD; Lowe TL; Budman CL; Erenberg G; Naarden A; Bruun RD; Schork NJ; Freimer NB; Reus VI
    Biol Psychiatry; 2007 Feb; 61(3):292-300. PubMed ID: 16581034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
    Steeves TD; Fox SH
    Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tourettism in multiple sclerosis: a case report.
    Nociti V; Fasano A; Bentivoglio AR; Frisullo G; Tartaglione T; Tonali PA; Batocchi AP
    J Neurol Sci; 2009 Dec; 287(1-2):288-90. PubMed ID: 19695578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comorbid disorders associated with tics].
    Fernández-Alvarez E
    Rev Neurol; 2002 Feb; 34 Suppl 1():S122-9. PubMed ID: 12447802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.